Reproductive and neurobehavioural toxicity study of tartrazine administered to mice in the diet.

Tartrazine was given in the diet to provide levels of 0% (control), 0.05%, 0.15%, and 0.45% (approximately 83, 259, 773 mg/kg/day, respectively) from five weeks of age of the F0 generation to nine weeks of age of the F1 generation in mice, and selected reproductive and neurobehavioural parameters were measured. In movement activity of exploratory behaviour in the F0 generation, number of vertical activity was significantly increased in the middle-dose group in males. There were no adverse effects of tartrazine on either litter size, litter weight and sex ratio at birth. The average body weight of male offspring was significantly increased in the high-dose group and that of female offspring was significantly increased in the middle-dose group at birth. In behavioural developmental parameters, surface righting at PND 4 was significantly accelerated in the high-dose group in male offspring, and those effects were significantly dose-related in a trend test (P<0.01). Cliff avoidance at PND 7 was significantly accelerated in the middle-dose group in male offspring. Negative geotaxis at PND 4 was significantly delayed in the high-dose group in female offspring. Other variables measured showed no significant adverse effects in either sex in the lactation period. In movement activity of exploratory behaviour in the F1 generation, number of movement showed a significant tendency to be affected in the treatment groups in male offspring in a trend test (P<0.05). The dose level of tartrazine in the present study produced a few adverse effects in neurobehavioural parameters during the lactation period in mice. Nevertheless, the high-dose level were in excess of the ADI of tartrazine (0-7.5 mg/kgbw), and the actual dietary intake of tartrazine is presumed to be much lower. It would therefore appear that the levels of actual dietary intake of tartrazine is unlikely to produce any adverse effects in humans.     

Reproductive and neurobehavioural toxicity study of bis(2-ethylhexyl) phthalate (DEHP) administered to mice in the diet.

Bis(2-ethylhexyl) phthalate (DEHP) was given in the diet to provide levels of 0 (control), 0.01, 0.03, and 0.09% from 5 weeks of age of the F0 generation to 9 weeks of age of the F1 generation in mice, and selected reproductive and neurobehavioural parameters were measured. There were no adverse effects of DEHP on either litter size, litter weight or sex ratio at birth. The average body weight of male offspring was significantly decreased in the low-dose group at birth. In behavioural developmental parameters, surface righting at PND 4 was significantly delayed in the low- and middle-dose group in female offspring, and those effects were slightly dose related (P < 0.05). Surface righting at PND 7 was significantly depressed in the high-dose group of male offspring, and those effects were significantly dose related (P < 0.001). That of female offspring was significantly depressed in the low-dose group. The dose level of DEHP in the present study produced few adverse effects in reproductive and neurobehavioural parameters in mice.     

Reproductive and neurobehavioural toxicity study of erythrosine administered to mice in the diet.

Erythrosine was given in the diet to provide levels of 0 (control), 0.005, 0.015 and 0.045% from 5 weeks of age of the F(0) generation to 9 weeks of age of the F(1) generation in mice, and selected reproductive and neurobehavioural parameters were measured. There were no adverse effects of erythrosine on either litter size, litter weight or sex ratio at birth. The average body weight of the offspring was significantly increased in the middle-dose group in both sexes during the lactation period. In behavioural developmental parameters, any variables showed no significant adverse effects in either sex in the lactation period. In movement activity of exploratory behaviour, several parameters were significantly changed in the high-dose group, and those effects were dose related in adult females in the F(0) and F(1) generations and in male offspring in the F(1) generation. The dose level of erythrosine in the present study produced few adverse effects in reproductive and neurobehavioural parameters in mice.     

Reproductive and neurobehavioural effects of bis(2-ethylhexyl) phthalate (DEHP) in a cross-mating toxicity study of mice.

Bis(2-ethylhexyl) phthalate (DEHP) was given in the diet to provide levels of 0% (C) or 0.03% (T) from 5 weeks of age of the F0 generation to 9 weeks of age of the F1 generation in mice. At 9 weeks of age, each female was paired with one male from the same or another treatment groups (cross-mating: C/C, T/C, C/T, T/T), for a period of 5 days. The selected reproductive and neurobehavioural parameters were measured. There were no adverse effects of DEHP on either litter size, litter weight and sex ratio at birth. The average body weight of female offspring was significantly affected in group IV (T/T) at PND 14. In behavioural developmental parameters, swimming direction at PND 4 was significantly accelerated in group III (C/T) in female offspring. In movement activity of exploratory behaviour at 3 weeks of age, number of movement of male offspring was significantly affected in group IV (T/T). The dose level of DEHP in the present cross-mating study produced few adverse effects in reproductive and neurobehavioural parameters in mice.     

Reproductive and neurobehavioural effects of phloxine administered to mice

The colour additive phloxine was given in the diet to provide dietary levels of 0 (control), 0.1, 0.3 and 0.9%, from 5 wk of age of the F₀ generation to 8 wk of age of the F₁ generation in mice, and selected reproductive and neurobehavioural parameters were measured. There was little effect of phloxine on either litter size or weight, or sex ratio, whereas the body weight of the pups in the lactation period was significantly increased in all treatment groups. Among the neurobehavioural parameters measured, surface righting at postnatal day 4 of male pups was significantly reduced in all treatment groups. Some parameters of the motor activity of pups at 3 wk of age differed from those of the controls; in particular, the average speed of movement male pups was significantly reduced in all treatment groups. The dose levels of phloxine in this study produced a few adverse effects in reproductive and neurobehavioural parameters in mice.     

Long-term toxicity study of Ponceau 4R in rats using animals exposed in utero

Groups of 66 (treated) or 114 (control) rats of each sex were fed diets providing 0 (control), 50, 500 or 1250 mg Ponceau 4R/kg body weight/day for 60 days. The animals were then mated and allowed to rear their litters. At weaning, pups were selected for the long-term study to give treated groups of 54 (of each sex) and a control group of 96 (of each sex), with offspring always receiving the same treatment as their parents. Treatment continued until approximately 20% of animals survived, resulting in a duration of 114 wk for males and 118 wk for females. Body weight, food and water intake and clinical conditions were monitored regularly throughout the study. Blood and urine from 20 rats/sex/group from the high-dose and control groups were examined at months 3, 6, 12, 18 and 24. At the end of the study each animal was autopsied, selected organs were weighed, and a full range of tissues was preserved. High-dose animals showed a lower body-weight gain without any reduction in food intake. Water intake was higher than that of the controls in the medium- and high-dose groups and this was related to caecal enlargement and softening of faeces. No adverse changes were seen in the investigations of blod or urine apart from a higher incidence of females with higher levels of protein in urine at the 1250 mg/kg/day dose. No other findings of significance were seen and survival and tumour incidence were similar in all groups. A no-untoward-effect level was established at 500 mg Ponceau 4R/kg/day.     

A three-generation reproduction study of Ponceau 4R in the rat

Ponceau 4R was fed to three generations of rats, at dietary concentrations to provide 0, 50, 500 or 1250 mg/kg body weight/day. In each generation treated groups consisted of 36 rats of each sex while 60 females served as controls. Apart from the F₀ generation, which started treatment as weanlings, treatment was continued throughout the study, providing in utero exposure of all offspring. The F₀ generation was bred twice, on the first occasion to provide animals for the next generation and for a long-term study, and a second time to provide data on in utero and post-partum development. In each generation approximately one third of the females from each group were killed before parturition to provide data on in utero development. The foetuses from these animals were examined for skeletal abnormalities. Remaining animals were allowed to litter and the offspring were monitored for 21 days after birth for survival and development. All animals were killed and subjected to a post-mortem examination which, for a proportion of each group in each generation, included recording of organ weights. Although a few adult rats died during the study these deaths were not associated with treatment. Fur of the treated animals was coloured pink, and faeces and caecal contents of animals from the two highest dose groups were yellow, the faeces also being softer than those of the controls. Treatment had no observed effect on clinical observations, body weight or food and water intake at any stage of the study. Animals fed the two highest doses for prolonged periods had enlarged caeca, but this effect was not seen in weanling animals on the same treatment. Neither the caecal enlargement nor the liver weights seen in the F₂ and F₃ offspring were considered to be an adverse effect of treatment. No treatment-related effects were seen in the uterine contents of females at any generation, but the skeletons of treated foetuses showed a slightly more advanced development than those of the controls. Postnatal development of offspring was not affected by treatment at any stage of the study. Tissues from the F₃ animals were examined by light microscopy and revealed no treatment-related effects. It is concluded that the no-adverse-effect level for Ponceau 4R is 1250 mg/kg body weight/day.     

Assessment of a two-generation reproductive and fertility study of mercuric chloride in rats.

Effects of mercuric chloride (MC) on the reproductive performance of two successive generations of rats was evaluated. F(0) rats were exposed to 0.0:0.0 (males:females), 0.50:0.75 (males:females), 1.00:1.50 (males:females) and 1.50:2.50 (males:females) mg/kg/day MC. Selected parental F(1) males and females were exposed to the same doses received by their parents (F(0)). Significant differences resulting from exposure of the F(0) generation to MC were found in implantation efficiency, fertility, live births and day 4 survival indices, litter size, and the body weight of F(1) pups. However, the continued exposure of the F(1) generation to MC did not affect fertility index or litter size, but did significantly affect implantation efficiency, live births and day 4 survival indices. In F(0) males, body weight and weights of the kidneys, testes, epididymides, prostate and seminal vesicles were significantly different, while in F(1) males, body weight, kidney weight, brain weight, liver weight and the weights of the testes, prostate and seminal vesicles were significantly different. In F(0) females, body weight and the weights of the kidneys, brain and liver were significantly different, while in F(1,) females, body weight, as well as the weights of the kidneys, liver, adrenals, uterus and ovaries were significantly different. These data showed that exposure to MC resulted in more adverse reproductive effects in the first generation and that these effects moderated in the second generation.     

Reproductive toxicity evaluation of dietary butyl benzyl phthalate (BBP) in rats

Butyl benzyl phthalate (BBP) was administered in the diet at 0, 750, 3750, and 11,250 ppm ad libitum to 30 rats per sex per dose for two offspring generations, one litter/breeding pair/generation, through weaning of F2 litters. Adult F0 systemic toxicity and adult F1 systemic and reproductive toxicity were present at 11,250 ppm (750 mg/kg per day). At 11,250 ppm, there were reduced F1 and F2 male anogenital distance (AGD) and body weights/litter during lactation, delayed acquisition of puberty in F1 males and females, retention of nipples and areolae in F1 and F2 males, and male reproductive system malformations. At 3750 ppm (250 mg/kg per day), only reduced F1 and F2 offspring male AGD was present. There were no effects on parents or offspring at 750 ppm (50 mg/kg per day). The F1 parental systemic and reproductive toxicity no observable adverse effect level (NOAEL) was 3750 ppm. The offspring toxicity NOAEL was 3750 ppm. The offspring toxicity no observable effect level (NOEL) was 750 ppm, based on the presence of reduced AGD in F1 and F2 males at birth at 3750 ppm, but no effects on reproductive development, structures, or functions.     

Reproductive Effects of 4-Vinylcyclohexene in Swiss Mice Assessed by a Continuous Breeding Protocol

4-Vinylcyclohexene (VCH), a dimer of 1,3-butadiene, was evaluatedfor reproductive toxicity in Swiss (CD-l) mice using the continuousbreeding protocol (NTP, 1989). VCH in corn oil was administeredby gavage at doses of 0, 100, 250, and 500 mg/kg/day to animalsthat were housed in same sex pairs for 1 week and then cohabitedin breeding pairs for 14 weeks. During cohabitation, newbornlitters were euthanized immediately after evaluation on postnatalDay (PND) 0. Litters born after Week 15 were reared until PND21, when all F₀ animals and low- and mid-dose F₁ weanlings werehumanely killed without a necropsy. At PND 74 ± 10, controland high-dose F animals were cohabited within groups for 1 weekand necropsied after delivery of the litters. In F breedingpairs, VCH did not affect measures of reproductive competence,including initial fertility, litters per pair, live litter size,or the proportion of pups born alive. Pup weight was decreased(4%) in the high-dose group relative to controls. High-doseF females exhibited slight general toxic ity, manifested asan 8% difference in body weight compared to controls. VCH didnot adversely affect preweaning growth or survival in the F₁generation. VCH had no effect on the reproductive competenceof the F₁ generation. High-dose F adult males and females haddecreased body weight. At necropsy, in creased relative liverweight (males 9% and females 8%) and sperm motility (althoughnot thought to be biologically significant) were observed inthe 500 mg/kg VCH group. Relative to controls, testicular spermatidcount was decreased by 17% by 500 mg/kg VCH treatment in thepresence of normal epididy mal sperm number and testis and epididymisweight. VCH treated females had significantly reduced numbersof primordial (33% decrease), growing (55% decrease), and antraloocytes(33% decrease) compared to controls, but ovarian weight andestrus cyclicity were unaffected. In summary, VCH, at doseswhich resulted in slight generalized toxicity (500 mg/kg/day),reduced the gamete pool in both the ovary (markedly) and testis(slightly) but had no significant adverse effect on the abilityto reproduce in either the F or F, generation.     

A thirteen week dietary toxicity study with 7-hydroxymatairesinol potassium acetate (HMRlignan) in rats

Plant lignan 7-hydroxymatairesinol (7-HMR) is a novel precursor of the mammalian lignan enterolactone. A 13 week toxicity study at dietary levels of 0, 0.25, 1, and 4% (w/w) of potassium acetate complex of 7-HMR (HMRlignan) was conducted in the Wistar rat. These dietary levels resulted in an average daily intake of 160, 640, and 2600 mg HMRlignan/kg body weight/day, respectively. A considerable systemic exposure of HMRlignan was verified by dose-related increases in plasma total (conjugated and unconjugated) concentration of 7-HMR and metabolites enterolactone, 7-hydroxyenterolactone, and matairesinol. Enterolactone appeared to be the major metabolite. Most (>96%) of the circulating 7-HMR and enterolactone was in conjugated form as measured from the low-dose rat plasma samples. HMRlignan exposure did not significantly affect clinical signs, ophthalmoscopy or neurobehavioural observations, and motor activity. Transient reductions in food intake and body weight gain in the mid-and high-dose group were ascribed to decreased palatability of the test feed. Only in males of the high-dose group the body weights remained slightly reduced throughout the study. In the high-dose group the number of thrombocytes (females), and total white blood cell count (males) were increased. Plasma triglycerides were dose-dependently depressed in males of all test groups and in females of the mid- and high-dose group, while plasma total cholesterol, and phospholipids were decreased in high-dose males. These changes, which have also been reported for other (flaxseed) lignans, were not considered to represent adverse effects. The relative weight of the kidneys was increased in males of the high-dose group. The weight of the full and empty caecum showed dose-related increases in males of all treatment groups and in females of the high-dose group. Absolute ovary weights were decreased in all treatment groups while decreases in relative ovary weights were confined to the mid- and high-dose group. In addition, a marginal lengthening of the estrus cycle was noted in high-dose females. Apart from prevention of hyaline droplet nephropathy in all high-dose male rats, there were no treatment-related histopathological alterations. It was concluded that HMRlignan showed weak antiestrogen-like activity which may be mediated through enterolactone metabolite. Based on declined ovary weight, the no observed adverse effect level of HMRlignan was set at 0.25% in feed corresponding to 160 mg/kg body weight/day.     

Two-generation reproduction study by dosing with glutaraldehyde in the drinking water of CD rats

Adult male and female CD rats (F0) were dosed with glutaraldehyde (GA; CAS number 111-30-8) in drinking water at concentrations of 0 (controls), 50, 250, or 1000 ppm for a 10-wk prebreed period and through mating, gestation, and lactation. Resultant F1 offspring, selected to be parents of the next generation, were continued on the same regime from prebreed through lactation. Twenty-eight parental animals per sex per generation for each dose group were evaluated for clinical signs, body weight (absolute and gain), and water and food consumption. The offspring were evaluated for survival and body weight to weaning. Necropsy and light microscopic examination of removed tissues were conducted in all F0 and F1 parents and in 10 offspring/sex/group/generation. Average daily consumptions of GA (as mean +/- SD) for the low, intermediate, and high concentrations were respectively 4.25 +/- 0.87, 17.50 +/- 4.16, and 69.07 +/- 14.58 mg/kg/d for F0 parental males, and 6.68 +/- 0.78, 28.28 +/- 4.09, and 98.37 +/- 11.71 mg/kg/d for F0 parental females. The corresponding values for the F1 parents were 4.53 +/- 1.02, 21.95 +/- 4.88, and 71.08 +/- 16.21 mg/kg/d for males and 6.72 +/- 0.84, 29.57 +/- 5.41, and 99.56 +/- 16.72 mg/kg/d for females. There were no effects on parental fertility and mating performance or on pup viability and litter size in any generation. No apparent treatment-related histopathology was seen in parents or offspring. Parental body weights and body weight gains were significantly reduced at 1000 ppm at a few isolated time periods, particularly during prebreed. Food consumption was significantly reduced at 1000 ppm for F0 and F1 parents during the prebreed and gestation periods, and at 250 ppm for F0 males during prebreed and gestation and F1 females during gestation and lactation. Water consumption by the F0 and F1 parents of the 250 at 1000 ppm groups was reduced throughout the prebreed period. At 1000 ppm, average litter weights were reduced over lactation d 21-28 for the F1 and F2 offspring. The no-observed-effect level (NOEL) for adult toxicity was 50 ppm and for offspring 250 ppm. There were no indications of reproductive toxicity, and the NOEL for this study was therefore > 1000 ppm.     

The effect of preconceptional exposure of F0 male mice to di(2-ethylhexyl)phthalate on the induction of reproductive toxicity in F2 generation

The aim of the study was the estimation of the effects of 8 weeks exposure mature and pubescent male mice to DEHP on the prenatal development of the offspring F2 generation.

The F1 offspring, of males exposed for whole cycle of spermatogenesis to DEHP (2000?mg/kg bw or 8000?mg/kg bw) and unexposed females, at 8–9?weeks of age were caged males with females from the same group, but from different litter.

Eight weeks preconceptional exposure of mature F0 males to 2000?mg/kg bw DEHP induced the significantly higher number of dead fetuses in the F2 offspring; however, the effect on the sperm count and quality of F1 males was not seen. Contrary, after such exposure of pubescent males not significantly decrease in the number of live implants was noted.

Results showed that the subchronical, preconceptional exposure of F0 males to DEHP did not influence strongly on the F2 generation of the offspring. Our study did not confirm higher sensitivity germ cells of pubescent males to harmful effects induced by DEHP. The developmental effect was present as the enhanced number of dead implants of F2 generation after exposure of mature F0 males and slight reduction in the number of live fetuses following the exposure of immature males. It may confirm ability to male mediated developmental toxicity.     

Effects of bis(2-ethylhexyl) phthalate (DEHP) on secondary sex ratio of mice in a cross-mating study.

Bis(2-ethylhexyl) phthalate (DEHP) was given in the diet to provide levels of 0 (C) or 0.03% (T) from 5 weeks of age of the F(0) generation to birth of the F(1) generation in mice. At 9 weeks of age, each female was paired with one male from the same or another treatment groups (cross-mating: C/C, T/C, C/T, T/T), for a period of 5 days. The males were removed from females after 5 days, and the females were allowed to carry their litters to term and deliver. There were no adverse effects of DEHP on either litter size, litter weight and sex ratio at birth. The average body weight of male offspring was significantly increased in all treatment groups at birth. There were no adverse effects of DEHP on female offspring weight at birth. The dose level of DEHP in the present study produced no adverse effects on secondary sex ratio, which meant sex ratio at birth, in mice.     

Three-generation reproduction study of rats receiving acrylonitrile in drinking water

Acrylonitrile, a high volume organic chemical, was tested for reproductive effects in a three generation drinking water study with two matings per generation. Sprague-Dawley rats were exposed to acrylonitrile in drinking water at 0, 100, or 500 ppm. This corresponds to 0, 11+/-5 and 37+/-10 mg/kg, respectively, for males and 0, 20+/-3 and 40+/-8 mg/kg per day for the females, respectively. Water consumption was reduced in F0 rats in the 100 and 500 ppm groups. At 500 ppm, acrylonitrile reduced body weight gain and food intake of the first generation parental rats (F0). These parameters were not investigated at subsequent generations. The pup survival (both viability and lactation indices) was reduced at the 500 ppm treatment level in both matings of all three generations. Fostering the 500 ppm pups onto untreated mothers following the second mating lessened mortality, suggesting a maternal effect consistent with decreased water consumption. There was no remarkable change in the reproductive capacity in any of matings in rats at the 100 ppm concentration. In contrast, in all three generations, the body weights of the pups of the 500 ppm treatment level were reduced on Day 21 at both matings. No adverse findings were observed in the tissues of a limited number of third generation weanlings (F3b) upon gross and microscopic evaluation. No effect on the sciatic nerve was evident among the adult female rats held for 20 weeks after weaning of the second litter. There was a dose-related effect of acrylonitrile on gross masses in female rats at each parental generation held 20 weeks after the weaning of the second litter. Histopathological evaluation of these dams showed an increase in astrocytomas and zymbal gland tumors.     

Three-Generation Reproduction Study with Dioctyl Sodium Sulfosuccinate in Rats

Three-Generation Reproduction Study with Dioctyl Sodium Sulfosuccinatein Rats. MACKENZIE, K., HENWOOD, S., FOSTER, G., AKIN, F., DAViS,R., DEBAECKE, P., SISSON, G., AND MCKINNEY, G. (1990). Fundam.Appl Toxicol. 15, 53–62. Groups of 30 male and 30 femalerats (F0) were fed diets containing 0, 0. 1, 0.5, or 1.0% dioctylsodium sulfosuccinate (DSS) for 10 and 2 weeks, respectively.The F0 animals were then mated to produce an F1 litter. Groupsof 30 male and 30 female F1 animals were fed the same dose levelsfor at least 10 weeks postweaning, and the breeding programwas repeated to produce F2 animals. F3 animals were producedfrom F2 animals by the same procedure. The study was terminatedwith the F3 wean lings. Test diets were fed continuously throughoutthe study. All F0, F1, and F2 adults and F3 weanlings (one/sex/litter)were necropsied and given a macroscopic examination. There wereno effects on reproductive function for parental animals ofeither sex during any of the three generations in this study.At the highest dose level (1.0% DSS), body weights were lowerthan those of controls dunng the premating phase for males inall three generations and for F1 and F2 females. Body weightsfor F1 and F2 males and females in the 0.5% dose group werealso low during the premating phase. Pup weights on LactationDay 0 were significantly lower than those of controls only forthe high-dose group during the third generation. However, lowerpup weight gains in the mid-and high-dose groups resulted insignificantly lower pup weights on Day 21 for all three generations.Perinatal pup survival across three generations ranged from96 to 100% for the control and treated groups. Pup survivalranged from 95 to 100% for controls, from 98 to 100% for low-and mid-dose groups, and from 91 to 99% for the high-dose group.There were no treatment-related mortality and antemortem ormacroscopic observations. In summary, DSS administered in thediet to three successive generations of rats at levels of 0.5and 1.0% caused a reduction in body weights for parental malesin all generations and for F1 and F2 females, Pup weights atthe 0.5 and 1.0% dose levels were also lower than those of thecontrol in all three generations. However, the reduced bodyweights did not interfere with development of normal reproductiveperformance. DSS at levels up to 1.0% had no effects on thereproductive function of either sex in any generation and producedno treatment-related antemortem or macroscopic observations.     

A short term peroral study of the food colour, Ponceau 6R in pigs

Ponceau 6R (the tetrasodium salt of 1-(4-sulpho-1-naphthyl-azo)-2-naphthol-3,6,8-trisulphonic acid) was fed to pigs at dietary levels of 0 (control), 100, 500 and 1500 mg/kg body wt./day for 102--105 days. In the 1500-mg group a decrease in weight gain and food utilization was seen, and 1 pig died with a hemolytic anaemia. Dose dependent discolouration was seen of the connective tissue in the groups given 1500 and 500 mg/kg body wt. For this effect the no-effect-level was 100 mg Ponceau 6R/kg body wt. per day.     

Reproductive toxicity of MCPA (4-chloro-2-methylphenoxyacetic acid) in the rat

The reproductive effects of the administration of 4-chloro-2-methylphenoxyacetic acid (MCPA) to rats were evaluated through two generations, from prior to mating, throughout mating, to gestation and lactation. MCPA was administered in the diet at doses of 0, 50, 150, or 450 ppm to 25 male and female immature rats (F0 parents) for 10 weeks. F0 parents were then mated to produce a first litter (F1a), retained only until weaning, and were subsequently remated to produce a second litter, F1b. Groups of male and female F1b animals were then dosed as were their parents for 10 weeks postweaning, and the breeding was repeated to produce F2a and F2b animals. The study concluded with the F2b weanlings. MCPA was administered continuously throughout the study. Only minimal, non-treatment-related observations were noted, which included rhinorrhea (in both treated and control animals in the F0 generation) and malocclusion and alopecia (in both the F0 and F1b generations). There were no consistent dose-related effects on reproductive function for parental animals of either sex in either generation. Statistically significant differences were noted in body weights and body weight gains in the 450-ppm dose group for both male and female pups in F2a and F2b. There were no treatment-related macroscopic or microscopic observations noted for any animal in this study. The no-observable-effect level (NOEL) for reproductive function in rats administered MCPA continuously for two successive generations was determined to be 450 ppm (approximately 22 mg/kg/day). The NOEL for general systemic toxicity, based on body weight effects in adult animals in the F1b generation was 150 ppm. The NOEL for effects on the offspring of the F1b generation, manifested as reduced pup weights and pup weight gains was also 150 ppm (approximately 8 mg/kg/day). Based upon the results of this study, MCPA, administered for two generations to Crl:CD(SD)BR Albino rats, is considered not to be a reproductive toxicant.     

Effects of piperonyl butoxide on F1 generation mice.

Piperonyl butoxide (PB), used in Japan as a pesticide synergist and food additive, was administered to mice from 5 weeks of age in the F0 generation to 9 weeks of age in the F1 generation, in the diet at levels of 0 (control), 0.15, 0.30 and 0.60%, and some reproductive, developmental and behavioral parameters were measured. Some parameters of open field activity were reduced in the treatment groups; in particular, ambulation and rearing were significantly reduced in F0 generation male mice and in 3-week-old F1 generation male mice. The weight of the pups was significantly reduced and litter weight tended to be reduced in the treatment groups. Body weight of dosed pups was reduced in the lactation period. Of the developmental parameters, olfactory orientation was significantly reduced as compared to controls. The dose levels of PB in this study, therefore, had an effect on some reproductive, developmental and behavioral parameters in mice.     

Evaluation of single-cell sources of docosahexaenoic acid and arachidonic acid: 3-month rat oral safety study with an in utero phase.

Owing to the presence of the polyunsaturated fatty acids (PUFA) docosahexaenoic acid (DHA) and arachidonic acid (ARA) in human milk and their important biological function, several authorities recommend that they be added to infant formulas. This study assessed the safety of an algal oil rich in DHA and a fungal oil rich in ARA, blended to provide a DHA to ARA ratio similar to human milk. The oil blend was incorporated into diets and fed to rats such that they received 3, 11 and 22 times the anticipated infant exposure to DHA and ARA. Low-fat and high-fat control groups received canola oil. Rats received experimental diets over a premating interval and throughout mating, gestation and lactation. Pups born during this period (F1) consumed treatment diets from weaning for 3 months. Physical observations, ophthalmoscopic examinations, body weight, food intake, clinical chemistry, neurobehavioural evaluations and postmortem histopathology of selected tissues were performed. No statistically significant, dose-dependent adverse effects were seen in reproductive performance or fertility, nor in the neonates from birth to weaning. Mid- and high-dose treated F1 animals exhibited increased white cell count, neutrophil count and blood urea nitrogen; increased liver and spleen weights (absolute and relative to body weight) also were observed. There were no corresponding microscopic findings. The clinical pathology and organ weight differences at these treatment levels represent physiological or metabolic responses to the test substance rather than adverse responses. These single-cell oils produced no adverse effects in rats when administered in utero and for 90 days at dietary levels resulting in exposures up to 22 or 66 times higher than those expected in infant formulas when extrapolated on the basis of diet composition (g/100 Cal) or intake (g/kg body weight), respectively.